Hypercalcemia - Symptoms, Causes, Treatment & Prevention

Overview

Hypercalcemia is a metabolic condition in which the calcium level in the blood is higher than normal. Normal total serum calcium ranges from 8.5 to 10.2 mg/dL (2.12–2.55 mmol/L). Hypercalcemia is generally diagnosed when levels are >10.2 mg/dL on at least two separate measurements.

Calcium is essential for bone health, muscle contraction, nerve transmission, and blood clotting. When excess calcium circulates, it disrupts these processes and may lead to a wide range of symptoms.

Although hypercalcemia can affect anyone, it is more common in adults over 50 years old and in patients with certain cancers, primary hyperparathyroidism, or chronic kidney disease. Epidemiologic data estimate that mild hypercalcemia (10.2‑11.9 mg/dL) occurs in 1–2 % of the general adult population, while severe hypercalcemia (>14 mg/dL) is rarer, affecting <0.1 % of people but accounting for up to 5 % of emergency department admissions for metabolic disturbances.^{[1] Mayo Clinic}

Symptoms

Symptoms often develop gradually and may be absent when calcium is only mildly elevated. When levels rise, signs involve multiple organ systems, commonly remembered by the mnemonic “Stones, Bones, Groans, Moans, and Psychiatric overtones.”

Renal (Kidney) Symptoms

• Kidney stones – calcium oxalate or phosphate stones causing flank pain, hematuria, and urinary urgency.
• Polyuria & polydipsia – excess calcium impairs the kidney’s ability to concentrate urine, leading to frequent urination and thirst.
• Nephrocalcinosis – calcium deposits in renal parenchyma that may progress to chronic kidney disease.

Skeletal Symptoms

• Bone pain – especially in the spine, ribs, and pelvis.
• Fractures – due to increased bone resorption.
• Osteopenia/osteoporosis – long‑term loss of bone density.

Gastrointestinal Symptoms

• Nausea & vomiting
• Constipation – calcium slows intestinal motility.
• Abdominal pain – may mimic peptic ulcer disease.
• Loss of appetite and weight loss.

Neurologic & Psychiatric Symptoms

• Fatigue, weakness, and lethargy
• Confusion, disorientation, or “brain fog.”
• Depression or anxiety
• Psychosis, delirium, or seizures – more common when calcium >14 mg/dL.

Cardiovascular Symptoms

• Shortened QT interval on ECG – may predispose to arrhythmias.
• Hypertension and, in severe cases, cardiac arrest.

Causes and Risk Factors

Hypercalcemia is usually classified as primary (originating from a disorder of calcium regulation) or secondary (a consequence of another disease or medication).

Primary Causes

• Primary hyperparathyroidism – benign overgrowth (adenoma) of one or more parathyroid glands is the leading cause in >90 % of cases of persistent hypercalcemia in out‑patients.^{[2] NIH}
• Malignancy‑associated hypercalcemia – cancers that secrete parathyroid‑related protein (PTHrP) (e.g., squamous cell lung cancer, renal cell carcinoma) or cause bone destruction (multiple myeloma, breast cancer, lymphoma). Accounts for ~20‑30 % of hypercalcemia cases in hospitalized patients.^{[3] CDC}
• Familial hypocalciuric hypercalcemia (FHH) – rare genetic mutation (CASR gene) causing lifelong mild hypercalcemia.

Secondary Causes

• Medications – thiazide diuretics, lithium, vitamin D intoxication, calcium supplements (>2 g/day), and certain antacids.
• Granulomatous diseases – sarcoidosis, tuberculosis, and some fungal infections produce excess 1,25‑dihydroxyvitamin D.
• Prolonged immobilization – especially in patients with high bone turnover (e.g., spinal cord injury).
• Endocrine disorders – hyperthyroidism, adrenal insufficiency.
• Renal failure – impaired excretion of calcium and vitamin D metabolites.

Risk Factors

• Age >50 years
• History of cancer (especially lung, breast, multiple myeloma)
• Family history of hyperparathyroidism or FHH
• Use of calcium‑rich supplements or high‑dose vitamin D
• Chronic kidney disease (CKD) stage 3‑5
• Medications listed above

Diagnosis

Diagnosis starts with a suspicion based on symptoms and risk factors, followed by laboratory evaluation and imaging when needed.

Laboratory Tests

1. Serum total calcium (corrected for albumin) – first screening test.
2. Ionized calcium – more accurate in critically ill patients.
3. Parathyroid hormone (PTH) – differentiates PTH‑mediated (high/normal) from non‑PTH‑mediated (low) hypercalcemia.
4. 25‑hydroxyvitamin D and 1,25‑dihydroxyvitamin D – assess vitamin D excess or deficiency.
5. Serum phosphorus – low in primary hyperparathyroidism, variable in malignancy.
6. Creatinine & eGFR – evaluate kidney function.
7. PTH‑related protein (PTHrP) – ordered when malignancy is suspected.
8. Serum alkaline phosphatase – may be elevated with high bone turnover.

Imaging Studies

• Neck ultrasound or sestamibi scan – locate abnormal parathyroid tissue.
• Chest X‑ray/CT – evaluate for lung malignancies.
• Bone scan, skeletal survey, or MRI – detect lytic lesions in multiple myeloma or metastatic disease.
• Renal ultrasound – check for nephrolithiasis or nephrocalcinosis.

Diagnostic Algorithm (simplified)

1. Confirm elevated calcium on two separate occasions.
2. Measure PTH:
   • High/normal → likely primary hyperparathyroidism or FHH.
   • Low → consider malignancy, vitamin D toxicity, granulomatous disease, medications.
3. If PTH low, order PTHrP, vitamin D levels, and appropriate imaging based on clinical suspicion.

Treatment Options

Treatment is guided by the severity of hypercalcemia, underlying cause, and patient’s overall health.

General Principles

• Restore calcium to the normal range (8.5‑10.2 mg/dL) as quickly as safely possible.
• Address the underlying etiology to prevent recurrence.
• Hydration and diuresis are first‑line for most acute cases.

Acute Management (Calcium >14 mg/dL or symptomatic)

1. Intravenous isotonic saline – 1–3 L over the first 12 hours to correct volume depletion and enhance renal calcium excretion.
2. Loop diuretics (e.g., furosemide) – added after re‑hydration to promote calciuresis; avoid thiazides.
3. Bisphosphonates (e.g., zoledronic acid 4 mg IV single dose or pamidronate 60–90 mg IV) – inhibit bone resorption; effect seen in 2–4 days, lasting 1–2 weeks.
4. Calcitonin – rapid but short‑lived drop in calcium (6‑12 h); useful while waiting for bisphosphonate effect.
5. Denosumab (120 mg SC) – anti‑RANKL antibody, effective in bisphosphonate‑refractory cases, especially in chronic kidney disease.
6. Glucocorticoids – 4–8 mg dexamethasone IV or oral prednisone 40 mg/day for vitamin D–mediated hypercalcemia (e.g., granulomatous disease).
7. Dialysis – reserved for severe renal failure, refractory hypercalcemia, or when fluid overload precludes aggressive hydration.

Long‑Term Management

• Primary hyperparathyroidism – surgical removal of the overactive gland(s) (parathyroidectomy) is curative in >95 % of cases.^{[4] Cleveland Clinic}
• Malignancy‑associated – treat the cancer (surgery, chemotherapy, radiation) plus bisphosphonates or denosumab for bone‑related hypercalcemia.
• Medication‑induced – discontinue offending agents; replace thiazides with alternative antihypertensives.
• Vitamin D intoxication – stop supplements, limit sun exposure, consider corticosteroids.

Lifestyle & Supportive Measures

• Maintain adequate hydration (2–3 L water daily unless contraindicated).
• Avoid high‑calcium foods and supplements (>1 g elemental calcium per day).
• Limit vitamin D intake to the recommended 600–800 IU/day unless prescribed.
• Monitor serum calcium regularly (every 3–6 months) after treatment.

Living with Hypercalcemia

Managing hypercalcemia is a partnership between you and your healthcare team. Below are practical tips for day‑to‑day life.

Medication Adherence

• Take calcium‑lowering meds exactly as prescribed.
• Keep a medication list and share it with every new provider.

Nutrition

• Focus on a balanced diet rich in fruits, vegetables, whole grains, and lean protein.
• Limit dairy products, fortified orange juice, and calcium‑rich cheeses if your doctor advises.
• Use calcium‑free multivitamins; read labels for hidden calcium (e.g., calcium carbonate as a filler).

Hydration

• Carry a water bottle; set reminders to drink every hour.
• If you have heart failure or kidney disease, discuss safe fluid limits with your doctor.

Physical Activity

• Weight‑bearing exercises (walking, resistance training) help maintain bone density, especially after parathyroid surgery.
• Avoid intense activities that could cause fractures if you have osteoporosis.

Regular Monitoring

• Schedule follow‑up labs as recommended (usually every 3–6 months).
• Report new symptoms promptly—especially fatigue, abdominal pain, or urinary changes.

Emotional Well‑Being

• Depression or anxiety can accompany chronic disease; consider counseling or support groups.
• Mind‑body techniques (meditation, yoga) may improve overall quality of life.

Prevention

While you cannot prevent all cases (e.g., genetic or cancer‑related), many triggers are modifiable.

• Use calcium supplements only when medically indicated.
• Avoid excessive vitamin D intake. The tolerable upper intake level for adults is 4,000 IU/day.^{[5] WHO}
• Regular screening for calcium levels in people with known risk factors (e.g., family history of hyperparathyroidism, CKD, long‑term thiazide use).
• Quit smoking and limit alcohol—both reduce cancer risk, a major cause of secondary hypercalcemia.
• Maintain healthy weight and stay active to lessen bone turnover associated with immobilization.

Complications

If hypercalcemia remains untreated or is recurrent, it can affect multiple organ systems.

• Nephrolithiasis & chronic kidney disease – repeated stone formation and calcification in renal tissue.
• Osteoporosis & pathological fractures – due to chronic bone resorption.
• Cardiovascular events – arrhythmias, hypertension, and increased risk of myocardial infarction.
• Neurocognitive impairment – persistent fatigue, memory problems, and mood disorders.
• Pancreatitis – rare but reported when calcium >14 mg/dL.
• Life‑threatening hypercalcemic crisis – can cause coma, coma‑like states, and death if not rapidly corrected.

When to Seek Emergency Care

---

References

1. Mayo Clinic. Hypercalcemia. https://www.mayoclinic.org/diseases-conditions/hypercalcemia/symptoms-causes/syc-20355523 (accessed April 2026).
2. National Institutes of Health (NIH). Primary hyperparathyroidism. https://www.niddk.nih.gov/health-information/endocrine-diseases/primary-hyperparathyroidism (accessed April 2026).
3. Centers for Disease Control and Prevention (CDC). Cancer‑related hypercalcemia. https://www.cdc.gov/cancer/cancerspecific/hypercalcemia.htm (accessed April 2026).
4. Cleveland Clinic. Parathyroidectomy for primary hyperparathyroidism. https://my.clevelandclinic.org/health/treatments/15033-parathyroidectomy (accessed April 2026).
5. World Health Organization (WHO). Vitamin D: safe upper intake levels. https://www.who.int/news-room/fact-sheets/detail/vitamin-d (accessed April 2026).